5303 篇
13870 篇
408835 篇
16090 篇
9269 篇
3870 篇
6469 篇
1239 篇
72413 篇
37118 篇
12061 篇
1621 篇
2824 篇
3387 篇
640 篇
1229 篇
1965 篇
4869 篇
3823 篇
5299 篇
东南亚制药和医疗保健行业报告(2019-2020年)
Southeast Asia Pharma and Healthcare Sector Report 2019-2020
With 1.4bn population each as of 2017, India and China are the most numerous countries out of the six forming the focus of this report. However, the two countries differ widely in terms of per capita GDP, with that of China being more than twice that of India. In 2017, India reported a fertility rate of 2.1 against only 1.5 for China, suggesting that the Chinese population is ageing at a faster rate compared to that of India. Observed life expectancy for both sexes increased between 1990 and 2017 in both China and India, but as of 2017, China reported higher life expectancy for both men and women compared to India. Thus, China first of the two countries will have to deal with substantial masses of senior population who will pose specific demands on its healthcare policies and facilities, as well as on the range of drugs available in the country. Of the six countries under review, Thailand is home to the most rapidly ageing population. The country reported 15.8% citizens aged 60+ in 2015, a share that is expected to grow to 26.9% in 2030, Global Age Index 2015 data showed. This places the country third in terms of ageing population in Asia, after Japan and South Korea. China ranks fourth.
01 EXECUTIVE SUMMARY
02 INDIA
03 CHINA
04 INDONESIA
05 MALAYSIA
06 THAILAND
07 THE PHILIPPINES